Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Sonic27on Jan 03, 2018 10:07am

55 Views

Post# 27269942

RE:8 frigging million shares DUMPED by Parente

NakedAndAfraid wrote:
In the middle of a NEWS bomb and massive PUMP DUMP..You can't cover this IROC needs to look into this..SJL had a similar situation and many are now under MCTO and a ASC investigation..I expect the Regulatory halt here soon...

Looking at the time you spend bashing here, you have nothing else to do?
Nobody care the sh!t you are vomiting

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects